These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Imaging cognitive and behavioral symptoms in Parkinson's disease. Antonelli F; Ray N; Strafella AP Expert Rev Neurother; 2010 Dec; 10(12):1827-38. PubMed ID: 21091314 [TBL] [Abstract][Full Text] [Related]
5. The use of PET in Parkinson's disease. Shinotoh H; Calne DB Brain Cogn; 1995 Aug; 28(3):297-310. PubMed ID: 8546856 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease. Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease: in vivo assessment of disease progression using positron emission tomography. Au WL; Adams JR; Troiano AR; Stoessl AJ Brain Res Mol Brain Res; 2005 Mar; 134(1):24-33. PubMed ID: 15790527 [TBL] [Abstract][Full Text] [Related]
15. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342 [TBL] [Abstract][Full Text] [Related]
16. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. Borghammer P; Cumming P; Aanerud J; Gjedde A Neuroimage; 2009 Apr; 45(2):249-57. PubMed ID: 18718541 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the progression of Parkinson's disease: a metabolic network approach. Eckert T; Tang C; Eidelberg D Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of Parkinson's disease]. Arias-Rodríguez M; Morís-De la Tassa G Rev Neurol; 2009 Jan; 48 Suppl 1():S21-5. PubMed ID: 19222011 [TBL] [Abstract][Full Text] [Related]
19. How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? Morrish PK Mov Disord; 2003 Oct; 18 Suppl 7():S63-70. PubMed ID: 14531048 [TBL] [Abstract][Full Text] [Related]
20. Development of Parkinson's disease biomarkers. Prakash KM; Tan EK Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]